We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

007310:KRXOTOKI Corporation Analysis

Data as of 2026-03-12 - not real-time

₩376,500.00

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Otoki Corporation is trading at 376,500 KRW, which sits below its 20‑day, 50‑day and 200‑day moving averages (388,525 KRW, 385,810 KRW and 393,125 KRW respectively), signaling a short‑term pullback. The MACD is in a bearish configuration and the RSI at 45.7 points to neutral momentum, while volume is trending upward, suggesting accumulation despite the price weakness. On the valuation side, the discounted cash‑flow model implies a fair value near 2,401,000 KRW, translating to roughly 38 % upside from the current level, and the forward P/E of 10.6 remains reasonable for a consumer‑defensive staple. The company delivers a solid 2.43 % dividend yield with a modest 30 % payout ratio, supported by healthy operating cash flow and a low‑beta (0.21) profile, which cushions market swings. However, a 30‑day volatility of over 31 % and a recent max drawdown of ‑17 % highlight notable price swing risk, even as the sector’s defensive nature and the prevailing “greed” sentiment (Fear‑Greed Index 74) provide a supportive backdrop.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD and price below key moving averages
  • Neutral RSI indicating no strong overbought/oversold signal
  • Rising volume suggesting potential accumulation

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • DCF‑derived upside of ~38 % versus current price
  • Reasonable forward P/E around 10.6 for a defensive staple
  • Attractive dividend yield with sustainable payout

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Low beta and defensive consumer‑defensive sector positioning
  • Stable cash flow generation and modest revenue growth
  • Consistent dividend policy reinforcing total return

Key Metrics & Analysis

Financial Health

Revenue Growth5.70%
Profit Margin2.75%
P/E Ratio10.6
ROE4.52%
ROA3.15%
Debt/Equity37.34
Op. Cash Flow₩213.9B
Free Cash Flow₩9.8B

Technical Analysis

TrendNeutral
RSI45.7
Support₩351,500.00
Resistance₩414,000.00
MA 20₩388,525.00
MA 50₩385,810.00
MA 200₩393,125.00
MACDBearish
VolumeIncreasing
Fear & Greed Index74.14

Valuation

Fair Value₩2,401.85
Target Price₩520,000.00
Upside/Downside38.11%
GradeUndervalued
TypeBlend
Dividend Yield2.43%

Risk Assessment

Beta0.21
Volatility31.53%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.